CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization (CRO), has formed a collaboration with Vtesse Inc. on a novel Phase 2b/3 clinical trial for the treatment of Niemann-Pick Type C1 (NPC) Disease. NPC is a genetic disease affecting an estimated one in 100,000 to 150,000 children who typically exhibit progressive impairment of motor and intellectual function, and often die before adulthood. Ground-breaking work in animal...